Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment

Creative Commons License

Yalcin A. D., Bisgin A., Kargi A., Gorczynski R. M.

MEDICAL SCIENCE MONITOR, cilt.18, sa.3, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.12659/msm.882504
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: severe persistent allergic asthma, allergic asthma, soluble TRAIL, omalizumab, RHEUMATOID-ARTHRITIS, APOPTOSIS, RHINITIS, STRAIL, CELLS, EXPRESSION, SURVIVAL, LIGAND, DEATH, FAS
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Background: In this study we compare the Omalizumab treatment modality in the dynamics of cell apoptosis regulating molecules in both severe persistent asthma patients who had no other any allergic disease, newly diagnosed patients with allergic asthma, and healthy volunteers.